Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the diseaseFrank Martiniuk, Paul H. Plötz, William J. Codd et al.|American Journal of Medical Genetics|1998Cited by 214
Helios Gene Gun Particle Delivery for Therapy of Acid Maltase DeficiencyFrank Martiniuk, William N. Rom, Vincent Donnabella et al.|DNA and Cell Biology|2002Cited by 10
Preclinical studies for plant-based oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice with transgenic tobacco seeds expressing human GAA (tobrhGAA)Frank Martiniuk, Kam-Meng Tchou-Wong, Adra Mack et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
Pre-clinical studies for oral enzyme replacement therapy in Pompe disease knockout mice with tobacco seeds expressing human GAAFrank Martiniuk, Kam-Meng Tchou-Wong, Adra Mack et al.|Gene & Protein in Disease|2025Cited by 1
Crotamine as a vehicle for non-viral gene delivery for Pompe diseaseFrank Martiniuk, Kam-Meng Tchou-Wong, Adra Mack et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0